GlobeStar Therapeutics Corporation
GlobeStar Therapeutics Corporation
Your view on GSTC
Overview
What the company does, where it operates, and who runs it.
About GlobeStar Therapeutics Corporation
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- James C. Katzaroff
- Headquarters
- 719 Jadewin Avenue, Richland, WA, US
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- James C. Katzaroff
- Headquarters
- 719 Jadewin Avenue, Richland, WA, US
GlobeStar Therapeutics Corporation, a clinical stage pharmaceutical company, focuses on developing a patented formulation of drugs for the treatment of multiple sclerosis and other neurodegenerative diseases. The company was formerly known as AngioSoma, Inc. and changed its name to GlobeStar Therapeutics Corporation in July 2021. The company was incorporated in 2016 and is based in Richland, Washington.
Infographics
Visual summary of the business at a glance.
Media
Videos and interviews covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks the stock is worth vs. the current price.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Comparables
List of peer companies in the same industry.
Institutional Ownership
Which funds and firms own the stock.
Insider Trading
Recent buying and selling by company executives.
Senate Trading
U.S. Senator disclosures filed under the STOCK Act.
News
Latest headlines and market coverage.